Yolanda Negrete
Family · Harlingen, TXNPI 1720733116
Payments from drug & device makers
Across 182 payments — averaging $24.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$979
- Inspire Medical Systems, Inc.$622
- Actelion Pharmaceuticals US, Inc.$407
- GSK$369
- Mylan Specialty L.p.$343
- Viatris Specialty LLC$282
- plus $1K from 17 others
What the payments were for
- Travel & lodging$3307%
- Food & beverage$4,01991%
- Education$651%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $979 |
| Inspire Medical Systems, Inc. | 8 | $622 |
| Actelion Pharmaceuticals US, Inc. | 12 | $407 |
| GSK | 27 | $369 |
| Mylan Specialty L.p. | 15 | $343 |
| Viatris Specialty LLC | 12 | $282 |
| Lilly USA, LLC | 8 | $218 |
| Insmed, Inc. | 21 | $208 |
| Electromed, Inc. | 17 | $166 |
| United Therapeutics Corporation | 2 | $137 |
| Boehringer Ingelheim | 5 | $98 |
| Verona Pharma, Inc. | 4 | $98 |
| Philips North America LLC | 6 | $97 |
| Johnson & Johnson | 3 | $67 |
| Baxter Healthcare | 3 | $66 |
| Paratek Pharmaceuticals, Inc. | 3 | $56 |
| Merck | 2 | $56 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Sanofi | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Exact Sciences | 1 | $20 |
| Bayer | 1 | $19 |
| Novo Nordisk | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,415 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 272 | $300,319 |
| Breo ElliptaFluticasone/Vilanterol | 101 | $62,100 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 63 | $51,666 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 61 | $39,577 |
| Spiriva RespimatTiotropium Bromide | 15 | $9,480 |
| SymbicortBudesonide/Formoterol Fumarate | 21 | $8,174 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 144 | $4,519 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 19 | $4,488 |
| BreynaBudesonide/Formoterol Fumarate | 14 | $3,085 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 11 | $2,637 |
| Ventolin HfaAlbuterol Sulfate | 23 | $1,904 |
| Montelukast Sodium | 117 | $1,181 |
| Levalbuterol Tartrate HfaLevalbuterol Tartrate | 15 | $945 |
| Fluticasone Propionate | 47 | $933 |
| Theophylline ErTheophylline Anhydrous | 25 | $919 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $369 | $414,085436 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $979 | $47,75182 claims |
| Boehringer IngelheimSpiriva Respimat | $98 | $9,48015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 15,456 family providers in Texas.
Other family in Harlingen
- Laura SaucedoHarlingen$44K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.